Bilateral Boston keratoprosthesis type 1 in a case of severe Mooren's ulcer.

CONCLUSION: Mainstay treatment of Mooren's ulcer is systemic immunomodulation. Surgical treatment must be considered only when risk of perforation, preferably with inflammation under control. Penetrating keratoplasty frequently fails, and Boston keratoprosthesis may be a viable option. However, postoperative complications, especially uncontrolled high intraocular pressure, corneal necrosis, and recurrence of Mooren's ulcer may jeopardize the outcomes and need to be addressed promptly with intensive topical and systemic treatment. PMID: 32141311 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32141311?dopt=Abstract

Source: European Journal of Ophthalmology - March 5, 2020 Category: Opthalmology Authors: Jerez-Peña M, Salvador-Culla B, de la Paz MF, Barraquer RI Tags: Eur J Ophthalmol Source Type: research